AusperBio to Present Two Posters on AHB-137, a Novel Antisense Oligonucleotide for Hepatitis B at EASL™ Congress 2023 ...Middle East

PR Newswire - News
AusperBio to Present Two Posters on AHB-137, a Novel Antisense Oligonucleotide for Hepatitis B at EASL™ Congress 2023
Data will highlight the preclinical antiviral activity, pharmacokinetic property, and safety profile of AHB-137, a potential best-in-class antisense oligonucleotide (ASO) for the treatment of chronic Hepatitis B (CHB). SAN FRANCISCO, June 12, 2023 /PRNewswire/ -- Ausper Biopharma Co., Ltd....

Hence then, the article about ausperbio to present two posters on ahb 137 a novel antisense oligonucleotide for hepatitis b at easl congress 2023 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AusperBio to Present Two Posters on AHB-137, a Novel Antisense Oligonucleotide for Hepatitis B at EASL™ Congress 2023 )

Apple Storegoogle play

Last updated :

Also on site :